Home › Digestive System Cancer › North Carolina
Digestive System Cancer clinical trials in North Carolina
3 studies for Digestive System Cancer are looking for participants at sites in North Carolina.
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Duke Cancer Center Cary, Cary
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222800KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07406633A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
- USA01-0, Huntersville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT07263594From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.